Under construction – not a live service
Sign in
Taking people in FranceNo phase

Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis

Key facts

Who runs it
Nantes University Hospital
Where
Nantes, FranceSee the site
Trial code
Status
Recruiting
People taking part
30 people, planned
Started
26 May 2026
Expected to end
26 May 2028
Type of study
Interventional
Treatments tested
  • synovial biopsies
Record updated
25 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Diagnosis of early osteoarthritis defined by the following clinical criteria:; score ≤ 85% in at least two of the four categories of the KOOS questionnaire: pain, symptoms/signs, function and quality of life; presence of tenderness on palpation of the joint space or crepitus (clinical examination); Kellgren and Lawrence (KL) score of 0 or 3 (X-rays)
  • Referred for therapeutic management including an intra-articular injection in the affected knee
  • Patient affiliated with a social security scheme
  • Patient able to understand the protocol and having signed an informed consent form

Who cannot take part

  • Thrombocytopenia < 50,000 platelets/mm3
  • Minors
  • Adults under guardianship or trusteeship
  • Pregnant women
  • Breastfeeding women
  • Protected patients
  • Curative anticoagulation
  • Patients who object to participating in the study

Where in France

  • CHU de NantesNantes, FranceContact: Benoit Le GoffTaking people

About the trial

What the trial wants to find out

Osteoarthritis is a common disease whose prevalence continues to increase. To date, there is no medical treatment that has proven effective, and only symptomatic treatments exist, mainly to reduce pain.

Read full original descriptionShow less

Arthroplasty, a costly and invasive surgical procedure, is often unavoidable in advanced stages of the disease. More than just a degenerative disease of the cartilage, osteoarthritis is now recognised as a heterogeneous disease causing multi-tissue damage of varying intensity. Synovitis plays a particularly important role in the onset and progression of osteoarthritis and has been closely correlated with radiographic severity, pain and loss of joint function. The investigators have identified several synovial histological pathotypes based on the type of synovial cell infiltrate and its distribution in samples from advanced osteoarthritis (surgical waste from prosthesis implantation). The investiogators' studies show that the presence of these pathotypes appears to be related to the clinical phenotype of patients. Analysis of synovial tissue at earlier stages of the disease is now essential to advance the understanding of the role of synovitis in osteoarthritis and its link to the clinical phenotype of patients.

The objective of this protocol is to describe the different synovial histological pathotypes present in the early stages of osteoarthritis; To this end, the investigators will establish a cohort of osteoarthritis patients with a collection of synovial tissue samples obtained by ultrasound-guided needle biopsy in an outpatient setting, a well-tolerated procedure with simple follow-up, as well as blood sampling.

The group in the trial

  • Biopsy groupOther group

    Treatment: synovial biopsies

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
25 June 2026